decreased circulating VLDL cholesterol level_Apob<tm1.1Zc>/Apob<+>

http://metadb.riken.jp/0005146I129X1SvJC57BL6Apobtm11ZcApobApobApobtm11Zc

decreased circulating VLDL cholesterol level_Apob<tm1.1Zc>/Apob<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• apolipoprotein B
  http://metadb.riken.jp/db/mgi_rdf/MGI:88052

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Apob<tm1.1Zc>/Apob<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Apob<+>|Apob<tm1.1Zc>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating VLDL cholesterol level
  http://purl.obolibrary.org/obo/MP_0005146

文献

http://purl.org/net/cito/citesAsAuthority

• Z. Chen, et.al., A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides., The Journal of biological chemistry, 2000, 275
  http://rdf.ncbi.nlm.nih.gov/pubmed/10893242